The hydroxycarboxylic acid (HCA) receptor family consists of three members, HCA1, HCA2, and HCA3, also known as GPR81, GPR109A, and GPR109B, respectively, which are encoded by closely related genes. The physiological ligands of HCA receptors are key metabolic intermediates whose local and systemic levels reflect particular metabolic states. Lactic acid, the end product of glycolysis, activates HCA1, whereas the ketone body 3-hydroxy-butyric acid [b-hydroxybutyrate (b-HB)] and the b-oxidation intermediate 3-hydroxy-octanoic acid activate HCA2 and HCA3, respectively. In addition, HCA2 is also activated by butyric acid. All three HCA receptors are highly expressed in white and brown adipocytes. Expressions of HCA1 and HCA2 have been shown to increase during differentiation of adipocytes from preadipocytes as well as after activation of peroxisome proliferator-activated receptor-gamma. Both high-fat diet (HFD) feeding and exposure to various inflammatory stimuli result in decreased expression of HCA1 in the adipose tissue. While HCA2 expression in the adipose tissue is also decreased after HFD feeding, inflammatory stimuli increase expression of HCA2. During the past decade, it has become clear that HCA receptors help to maintain homeostasis under changing metabolic and dietary conditions, by controlling metabolic, immune, and other body functions. Work based on genetic mouse models and synthetic ligands of HCA receptors has, in addition, shown that members of this receptor family can serve as targets for the prevention and therapy of diseases such as metabolic and inflammatory disorders.
3,5-Dihydroxybenzoic acid 是啤酒、坚果、花生和豆类等食物摄入的潜在生物标记,是羟基羧酸受体 1(HCA1,也称为 GPR81)的激动剂,可抑制脂肪细胞中的脂肪分解,也是酪氨酸酚裂解酶 (TPL) 的竞争性抑制剂(Ki=25.7 μM),并具有口服活性。
3,5-Dihydroxybenzoic acid (Standard) 是 3,5-Dihydroxybenzoic acid 的分析标准品,用于研究及分析应用;3,5-Dihydroxybenzoic acid 是啤酒、坚果、花生和豆类等食物摄入的潜在生物标记,是羟基羧酸受体 1(HCA1,也称为 GPR81)的激动剂,可抑制脂肪细胞中的脂肪分解,也是酪氨酸酚裂解酶 (TPL) 的竞争性抑制剂(亲和力 Ki=25.7 μM),并具有口服活性。
3-Hydroxybenzoic acid 是一种具有口服活性的内源性代谢产物,是 GPR81 和 GPR109A 的激动剂,可作为应激反应脱敏剂,并用于抗炎和镇痛研究。
3-Hydroxybenzoic acid (Standard) 是 3-Hydroxybenzoic acid 的分析标准品,该产品可用于研究及分析应用,而 3-Hydroxybenzoic acid 是一种具有口服活性的内源性代谢产物,作为 GPR81 和 GPR109A 的激动剂,它可作为应激反应脱敏剂并用于抗炎和镇痛研究。
3-Hydroxybenzoic acid-d4 是氘标记的 3-Hydroxybenzoic acid (MS-M17964),而 3-Hydroxybenzoic acid 是一种具有口服活性的内源性代谢产物,可作为 GPR81 和 GPR109A 的激动剂及应激反应脱敏剂,并用于抗炎和镇痛研究。
3-Chloro-5-hydroxybenzoic acid 是一种有效的、具有口服活性的选择性乳酸受体 GPR81 激动剂,对人 GPR81 的 EC50 为 16 μM,并在肥胖小鼠模型中显示出良好的体内脂肪分解作用。
5-OxoETE methyl ester 是氧代二十烷酸受体(oxoeicosanoid receptor 1,OXER1)的激动剂,可与 OXER1 结合并激活下游信号通路 β-arrestin 募集(β-arrestin recruitment),其 EC50 为 1.54 µM。
FCH-2296413 是一种强效且选择性的羟基羧酸受体 (HCAR) 激动剂,EC50 值为 4.4-8.6 nM,具有镇痛活性,可用于外周疼痛相关疾病的研究。
GPR81 agonist 1 是一种高效、高选择性的 GPR81 激动剂,对人和小鼠 GPR81 的 EC50 分别为 58 nM 和 50 nM,可抑制分化的 3T3-L1 脂肪细胞的脂解,抑制小鼠脂解时不会造成皮肤潮红,且对 GPR81 的选择性高于 GPR109a。
GPR81 agonist 2 (compound 1) 是一种有效的 GPR81 激动剂,对 hGPR81 和 hGPR109A 的 EC50 值分别为 0.023 µM 和 0.123 µM。
HCAR2 agonist 1 (Compound 9n) 是一种 Gi 蛋白偏向性 HCAR2 变构调节剂,可激活 Gi 蛋白信号传导通路,表现出抗炎作用并降低促炎细胞因子(TNF-α、IL-1β、IL-6 和 MCP-1)的 mRNA 水平,同时增强正位激动剂在结肠炎小鼠模型中的抗炎作用。
Lactic acid-13C2 (DL-Lactic acid-13C2) sodium 是 13C 标记的 Lactic acid sodium,而 Lactic acid (DL-Lactic acid) sodium 是一种羟基羧酸受体 1 (HCAR1) 激活剂和诱导赖氨酸残基乳酰化的表观遗传调节剂,作为糖酵解终产物弥补了糖酵解和氧化磷酸化之间的差距,也是一种在抗肿瘤免疫中具有乳酸免疫保护作用的肿瘤代谢物,同时还具有抗菌活性,可用作食品保鲜剂。